Role of HTLV-I in development of non-Hodgkin lymphoma in Jamaica and Trinidad and Tobago
- 11 December 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 342 (8885) , 1447-1450
- https://doi.org/10.1016/0140-6736(93)92931-i
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Treatment of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphomaBritish Journal of Haematology, 1991
- Human T-Lymphotropic Virus Type I (HTLV-I) Seroprevalence in JamaicaAmerican Journal of Epidemiology, 1991
- Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type IInternational Journal of Cancer, 1989
- HTLV-I—Associated B-Cell CLL: Indirect Role for Retrovirus in LeukemogenesisScience, 1987
- ESTIMATING THE POPULATION ATTRIBUTABLE RISK FOR MULTIPLE RISK FACTORS USING CASE-CONTROL DATAAmerican Journal of Epidemiology, 1985
- Racial and other characteristics of human T cell leukemia/lymphoma (HTLV-I) and AIDS (HTLV-III) in Trinidad.BMJ, 1985
- HTLV ANTIBODIES IN PATIENTS WITH NON-HODGKIN LYMPHOMAS IN MARTINIQUEThe Lancet, 1984
- National cancer institute sponsored study of classifications of non-hodgkin's lymphomas. Summary and description of a working formulation for clinical usageCancer, 1982
- Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemiaNature, 1981